Mozhdeh Heidari, Ramin Yaghobi, Mohsen Moghadami, Farid Zand, Mohammad Javad Fallahi, Ali Akbar Pourfathollah, Golnoush Zarnegar, Alireza Salah, Saeedeh Soleimanian, Mehdi Golshan, Ali Jangjoo, Mohammad Hossein Karimi
Following the outbreak of COVID-19, several immunotherapy methods were used to modulate the immune responses of patients. In this study, we aimed to evaluate the immune response to COVID-19 in patients receiving convalescent plasma. In this regard, this randomized controlled trial included 30 patients who were divided into two groups according to receiving convalescent plasma or normal control plasma. Samples from both groups were collected on days 0, 1, 3, 5 and 7 after plasma infusion. We measured the expression level of TLR7/8, IRF3/7, CTLA-4, PD-1 and T cell transcription factors by Real-time PCR in the mentioned groups...
October 8, 2024: Cellular and Molecular Biology